<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Tumor necrosis factor-alpha Tumor necrosis factors Bi-specific T-cell engager Interleukin Lymphotoxin T helper cell Interferon-gamma Federica Sallusto Dorian Bevec Cytokines Biology Immune system |
| Immunotherapy: Big Pharma’s Seductive Embrace The advent of the first wave of checkpoint inhibitors has the oncology community believing that immunotherapy will be foundational, in the same way that combination chemothDocID: 1grCr - View Document |
| Immunotherapy: Big Pharma’s Seductive Embrace The advent of the first wave of checkpoint inhibitors has the oncology community believing that immunotherapy will be foundational, in the same way that combination chemothDocID: 1gf3m - View Document |
| PDF DocumentDocID: 1aD8f - View Document |
| A novel immunotherapy technique to treat patients with osteosarcoma and neuroblastomaDocID: 12GMO - View Document |
| U N I T 5 : T H E L A N G U A G E P O L I T I C SDocID: 101CZ - View Document |